| Dr Christine Barabas, PHARMD, RPH | |
|
20 Woodruff Ave, Rite Aid Pharmacy, Narragansett, RI 02882-3423 | |
| (401) 792-7179 | |
| Not Available |
| Full Name | Dr Christine Barabas |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 20 Woodruff Ave, Narragansett, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083992804 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH05033 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christine Barabas, PHARMD, RPH 39 Greentree Rd, Clifton, NJ 07013-1706 Ph: (201) 803-4386 | Dr Christine Barabas, PHARMD, RPH 20 Woodruff Ave, Rite Aid Pharmacy, Narragansett, RI 02882-3423 Ph: (401) 792-7179 |
News Archive
Scientists from Virginia Commonwealth University Massey Cancer Center have provided evidence from preclinical experiments that a gene known as melanoma differentiation associated gene-9/syntenin (mda-9/syntenin) could be used as a therapeutic target to kill bladder cancer cells, help prevent metastasis and even be used to non-invasively diagnose the disease and monitor its progression.
The world's leading medical evacuation practitioners will be speaking at the 3rd Annual MEDEVAC conference, a two-day event providing insight into operating in austere environments, including lessons learnt from Afghanistan and the latest requirements and training plans for meeting operational demands.
Orthovita, Inc. , an orthobiologics and biosurgery company, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market Vitoss Bioactive Foam-2X Bone Graft Substitute for use as a non-structural bone void filler for use in the spine, pelvis and extremities. Orthovita expects to launch the newest addition to its bone graft substitute product line by late February or early March of 2011.
Controversy about the risks of measles, mumps, and rubella vaccines has been rumbling in the United States for years - and now it's Israel's turn. After finding traces of the polio virus in sewage, Israel's Ministry of Health launched a national vaccination campaign that reached more than half a million children. Surprisingly, dissenting voices flooded social media and the mainstream news, calling for a halt to the campaign.
Sanofi-aventis announced today a research collaboration with Harvard University. The goal of the collaboration is to advance knowledge in the area of human health through basic and applied research and to promote scientific exchange between Harvard University and sanofi-aventis. The focus of this collaboration is translational biomedical research in multiple therapeutic areas such as cancer, diabetes and inflammation.
› Verified 8 days ago
Cynthia T Cruser, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 20 Woodruff Ave, Narragansett, RI 02882 Phone: 401-741-8415 | |
Christine Markut, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1123 Boston Neck Rd, Narragansett, RI 02882 Phone: 401-783-1753 | |
Casey Adams, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 91 Point Judith Rd, Narragansett, RI 02882 Phone: 401-783-7768 | |
Dr. Stacey Ellen Kostarides, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 20 Woodruff Ave, Narragansett, RI 02882 Phone: 401-792-7179 Fax: 401-792-7184 | |
Cassandra Couture, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1123 Boston Neck Rd, Narragansett, RI 02882 Phone: 401-783-1753 | |
Linda Ann Carver, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 20 Woodruff Ave, Narragansett, RI 02882 Phone: 401-792-7179 Fax: 401-792-7184 |